# Sodium Channel Splicing in Heart Failure Trial (SOCS-HEFT) Prospective Study

> **NCT02738749** · NA · UNKNOWN · sponsor: **Rhode Island Hospital** · enrollment: 450 (estimated)

## Conditions studied

- Death, Sudden, Cardiac

## Interventions

- **DEVICE:** Implantable cardioverter-defibrillator (ICD)

## Key facts

- **NCT ID:** NCT02738749
- **Lead sponsor:** Rhode Island Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2019-07
- **Final completion:** 2020-07
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02738749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02738749, "Sodium Channel Splicing in Heart Failure Trial (SOCS-HEFT) Prospective Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02738749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*